Divis Labs (Bullish stance)

13 thg 4, 2022

Divis Labs:
Sector: Pharma and Biotechnology
Industry: Pharma

Divis Laboratories (Weekly):
1. Double Bottom
2. Breakout of Double Bottom
3. Positive Crossover of 5,13 Weeks Exponential Moving Average

Daily:
1. RSI Bullish Divergence and Double Bottom Breakout
2. Trendline Breakout
3. Good to buy above consolidation breakout (closing above 4590)
4. Positive crossover of 5,13 Days Exponential Moving Average
5. Trading above 200 Days Exponential Moving Average

Addl Points:
1. FII/FPI have decreased holdings from 19.30% to 18.45% in Mar 2022 qtr
2. Mutual Funds have increased holdings from 13.35% to 13.68% in Mar 2022 qtr.

Note:
1. The above analysis is just for educational purpose.